Serial #79219055
LIVE

Serial Number

79219055

Owner

Jiangsu Hengrui Medicine Co., Ltd.

Attorney

John Alumit

Filing Date

May 5, 2017

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79219055 Trademark

Serial Number: 79219055 • Registration: 5477993

Serial #79219055 is a trademark filed by Jiangsu Hengrui Medicine Co., Ltd. on May 5, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Jiangsu Hengrui Medicine Co., Ltd. (4 trademarks)

No. 38, Huanghe Road,

Entity Type: 16

Trademark Details

Filing Date

May 5, 2017

Registration Date

May 29, 2018

Published for Opposition

March 13, 2018

Cancellation Date

December 13, 2024

Goods & Services

Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sprays, balms, inhalants and sachets, injection based and ointment based pharmaceutical preparations, and medicine composed of raw materials, all for the treatment of cardiovascular and cardiopulmonary disorders, prevention and treatment of disorders of the nervous system, the immune system, the metabolic system, the respiratory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, for use in surgery, for the treatment of ophthalmological and astroenterological disorders, for the treatment of bacteria-based, fungus-based and viral diseases, for the treatment of diabetes, for the treatment of infectious diseases, allergies, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders, sexual dysfunction, hormonal and psychiatric diseases and disorders, for wound treatment, and for the treatment of sports related injuries in humans

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Mar 19, 2026 INNT
GENERIC MADRID TRANSACTION SENT TO IB
Feb 1, 2026 XXSS
GENERIC MADRID TRANSACTION CREATED
Feb 1, 2026 XXCR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Aug 13, 2025 INTR
CANCELLED SECTION 71
Dec 13, 2024 C71T
NEW REPRESENTATIVE AT IB RECEIVED
Jul 6, 2024 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
May 29, 2023 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 16, 2018 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Sep 12, 2018 XXSS
GENERIC MADRID TRANSACTION CREATED
Sep 12, 2018 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 29, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
May 29, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 13, 2018 NPUB
PUBLISHED FOR OPPOSITION
Mar 13, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 21, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 30, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 30, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 30, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 30, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 30, 2018 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 26, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 25, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 25, 2018 TROA
REFUSAL PROCESSED BY IB
Dec 1, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 13, 2017 RFCS
REFUSAL PROCESSED BY MPU
Nov 13, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 3, 2017 RFCR
NON-FINAL ACTION WRITTEN
Nov 2, 2017 CNRT
APPLICATION FILING RECEIPT MAILED
Oct 31, 2017 MAFR
ASSIGNED TO EXAMINER
Oct 25, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 25, 2017 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Oct 24, 2017 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 19, 2017 REPR